"In response to the need for mRNA COVID-19 vaccines during the pandemic, the manufacturing capacity for RNA was designed on ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

We initiated our '24-'25 COVID-19 commercial season in mid-September shortly after achieving ... Novavax is demonstrating the ability to compete with the mRNA vaccines. In one regional supplier of ...

Novavax’s COVID-19 vaccine won FDA approval in October 2023. It’s different from the mRNA vaccines developed by Pfizer Inc.

1 Saraf, et al (2024). An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial. Nat Med, 30(5), 1363-1372. 2 Alberer, et al (2017). Safety and ...

There is no evidence Japan has named the COVID-19 vaccine the “most deadly drug in history,” as the post claims.

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

(NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace's 2025 Best Places to Work report based on the Company's reputation and commitment to innovation. 'We are honored ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...